Bacillus atrophaeus inactivated spores as a potential adjuvant for veterinary rabies vaccine

被引:6
|
作者
Oliveira-Nascimento, L. [1 ]
Caricati, A. T. P. [1 ,2 ]
Abdulack-Lopes, F. [1 ]
Neves, L. C. M. [1 ]
Caricati, C. P. [2 ]
Penna, T. C. V. [1 ]
Stephano, M. A. [1 ]
机构
[1] Univ Sao Paulo, Fac Pharmaceut Sci, BR-0550800 Sao Paulo, SP, Brazil
[2] Butantan Inst, BR-05503900 Sao Paulo, SP, Brazil
关键词
Rabies; Vaccine; Bacillus atrophaeus; Saponin; Adjuvant; SUBTILIS SPORES; ANTIGEN;
D O I
10.1016/j.vaccine.2012.03.029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rabies is a viral encephalitis, nearly always fatal, but preventable through vaccines. Rabid animal bite is the prime transmission act, while veterinary vaccination is one of the best strategies for rabies general prevention. Aluminum compounds and saponin are the commercial adjuvants used for this vaccine nowadays. Nevertheless, aluminum compounds can provoke undesired side effects and saponin has a narrow activity range without toxicity. B. atrophaeus inactivated spores (BAIS), with or without saponin, were then used as an alternative to boost the inactivated rabies virus response. BAIS was as effective as saponin in augmenting antibody titers, but combination of both adjuvants doubled the titers raised by them individually. The combined adjuvant formulation maintained viability for 21 months when stored at 4-8 degrees C. Overall, BAIS was demonstrated as a viable alternative to commercial adjuvants, while its combination with saponin resulted in even higher vaccine potency with good stability. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3351 / 3354
页数:4
相关论文
共 50 条
  • [41] Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine
    Asgary, Vahid
    Shoari, Alireza
    Moayad, Majid Afshar
    Ardestani, Mehdi Shafiee
    Bigdeli, Razieh
    Ghazizadeh, Leila
    Khosravy, Mohammad Sadeq
    Panahnejad, Erfan
    Janani, Alireza
    Bashar, Rouzbeh
    Abedi, Maliheh
    Cohan, Reza Ahangari
    VIRAL IMMUNOLOGY, 2018, 31 (01) : 47 - 54
  • [42] MEDICAL PROPHYLAXIS OF ANIMAL RABIES - CHOICE OF AN INACTIVATED VACCINE
    SOULEBOT, JP
    BRUN, A
    CHAPPUIS, G
    GUILLEMIN, F
    PETERMANN, HG
    PRECAUSTA, P
    TERRE, J
    ANNALES DE VIROLOGIE, 1982, 133 (02): : 163 - 169
  • [43] Growth, development and thermal resistance of Bacillus atrophaeus spores using whey culture media
    Do Espirito, Santo Evellin
    Hertel, Lenhardt Elizandra
    Goncalves, Lousada Maria Eduarda
    Marina, Ishii
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2022, 17 (12): : 41 - 47
  • [44] Adjuvant activity of cordycepin, a natural derivative of adenosine from Cordyceps militaris, on an inactivated rabies vaccine in an animal model
    Chen, Xin
    Liao, Boyu
    Ren, Tianci
    Liao, Zhipeng
    Huang, Zijie
    Lin, Yujuan
    Zhong, Shouhao
    Li, Jiaying
    Wen, Shun
    Li, Yingyan
    Lin, Xiaohan
    Du, Xingchen
    Yang, Yuhui
    Guo, Jiubiao
    Zhu, Xiaohui
    Lin, Haishu
    Liu, Rui
    Wang, Jingbo
    HELIYON, 2024, 10 (02)
  • [45] The effectiveness of inactivated, purified and concentrated experimental rabies vaccine for veterinary use: Antigenic activity. Experiments on domestic dogs
    Benisek, Z
    Suliova, J
    Svrcek, S
    Zavadova, J
    Ondrejka, R
    Durove, A
    VETERINARNI MEDICINA, 1998, 43 (02) : 45 - 49
  • [46] Inactivation of vegetative cells, germinated spores, and dormant spores of Bacillus atrophaeus by pulsed electric field with fixed energy input
    Wu, Wen Jie
    Chang, Jinhui
    JOURNAL OF FOOD PROCESS ENGINEERING, 2022, 45 (02)
  • [47] A NOVEL ADJUVANT PROMISES IMPROVED RABIES VACCINE
    Nicholson, Stacia M.
    LAB ANIMAL, 2016, 45 (04) : 128 - 128
  • [48] A novel adjuvant promises improved rabies vaccine
    Stacia M. Nicholson
    Lab Animal, 2016, 45 : 128 - 128
  • [49] Adjuvant potential of resiquimod with inactivated Newcastle disease vaccine and its mechanism of action in chicken
    Sachan, Swati
    Ramakrishnan, Saravanan
    Annamalai, Arunsaravanakumar
    Sharma, Bal Krishan
    Malik, Hina
    Saravanan, B. C.
    Jain, Lata
    Saxena, Meeta
    Kumar, Ajay
    Krishnaswamy, Narayanan
    VACCINE, 2015, 33 (36) : 4526 - 4532
  • [50] Vaccine potential for inactivated shigellae
    Osorio, Manuel
    Bray, Mechelle D.
    Walker, Richard I.
    VACCINE, 2007, 25 (09) : 1581 - 1592